Skip to main content
Top
Published in: World Journal of Surgery 6/2010

01-06-2010

Excellent Prognosis of Patients with Solitary T1N0M0 Papillary Thyroid Carcinoma Who Underwent Thyroidectomy and Elective Lymph Node Dissection Without Radioiodine Therapy

Authors: Yasuhiro Ito, Hiroo Masuoka, Mitsuhiro Fukushima, Hiroyuki Inoue, Minoru Kihara, Chisato Tomoda, Takuya Higashiyama, Yuuki Takamura, Kaoru Kobayashi, Akihiro Miya, Akira Miyauchi

Published in: World Journal of Surgery | Issue 6/2010

Login to get access

Abstract

Background

The extent of surgery for papillary carcinoma significantly differs between western countries and Japan. Almost routine total thyroidectomy with radioiodine ablation therapy has been performed in western countries, whereas limited thyroidectomy has been adopted in Japan, especially for low-risk cases. In this study, the prognosis of patients with solitary papillary carcinoma measuring 2 cm or less without massive extrathyroid extension, clinically apparent lymph node metastasis or distant metastasis at diagnosis (T1N0M0 in the UICC TNM classification) was investigated to elucidate the appropriate extent of surgery for these patients.

Methods

We investigated the prognosis of 2,638 patients with solitary T1N0M0 papillary carcinoma who underwent initial surgery between 1987 and 2004. Total or near total thyroidectomy was performed for 1,037 patients and the remaining 1,601 patients underwent more limited thyroidectomy. Elective central node dissection was performed for 2,511 patients, accounting for 96%, and 1,545 (59%) also underwent prophylactic lateral node dissection. Radioiodine ablation therapy was performed only for three patients.

Results

The 10-year disease-free survival (DFS) rate of our series was 97%. To date, recurrence was observed in 62 patients (2%) and 41 showed recurrence to the regional lymph nodes. Seventeen of 1,601 patients who received limited thyroidectomy (1%) showed recurrence to the remnant thyroid. Pathological nodal-positive patients showed a worse DFS, but the 10-year DFS rate was still high at 96%. Patients with total or near total thyroidectomy had a better DFS, but the difference disappeared if recurrence to the remnant thyroid was excluded. A number needed to treat (NNT) for total or near total thyroidectomy over hemithyroidectomy was 83 to prevent 1 recurrence.

Conclusions

These findings suggest that solitary T1N0M0 patients have an excellent prognosis when they undergo thyroidectomy and elective lymph node dissection without radioiodine therapy. Regarding the extent of thyroidectomy, hemithyroidectomy is adequate for these patients, if a 1% risk of recurrence to the remnant thyroid is accepted.
Literature
1.
go back to reference Ito Y, Tomoda C, Uruno T et al (2005) Ultrasound-detectable and anatomopathologically detectable node metastasis in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29:917–920CrossRefPubMed Ito Y, Tomoda C, Uruno T et al (2005) Ultrasound-detectable and anatomopathologically detectable node metastasis in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29:917–920CrossRefPubMed
2.
go back to reference Ito Y, Tomoda C, Uruno T et al (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30:780–786CrossRefPubMed Ito Y, Tomoda C, Uruno T et al (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30:780–786CrossRefPubMed
3.
go back to reference Ito Y, Miyauchi A, Jikuzono T et al (2007) Risk factors contributing to a poor prognosis of papillary thyroid carcinoma. Validity of UICC/AJCC TNM classification and stage grouping. World J Surg 31:838–848CrossRefPubMed Ito Y, Miyauchi A, Jikuzono T et al (2007) Risk factors contributing to a poor prognosis of papillary thyroid carcinoma. Validity of UICC/AJCC TNM classification and stage grouping. World J Surg 31:838–848CrossRefPubMed
4.
go back to reference Ito Y, Kakudo K, Hirokawa M et al (2009) Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery 145:100–105CrossRefPubMed Ito Y, Kakudo K, Hirokawa M et al (2009) Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery 145:100–105CrossRefPubMed
5.
go back to reference Ito Y, Miyauchi A (2009) Prognostic factors and therapeutic strategies for differentiated carcinoma of the thyroid. Endocrine J 56:177–192CrossRef Ito Y, Miyauchi A (2009) Prognostic factors and therapeutic strategies for differentiated carcinoma of the thyroid. Endocrine J 56:177–192CrossRef
6.
go back to reference Mazzaferri EL, Kloos RT (2001) Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447–1463CrossRefPubMed Mazzaferri EL, Kloos RT (2001) Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447–1463CrossRefPubMed
7.
go back to reference Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA (1998) Unilateral total lobectomy: is it sufficient surgical treatment for patients with MES low-risk papillary thyroid carcinoma? Surgery 124:658–966 Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA (1998) Unilateral total lobectomy: is it sufficient surgical treatment for patients with MES low-risk papillary thyroid carcinoma? Surgery 124:658–966
8.
go back to reference Hay ID, Hutchinson ME, Gonzalez-Losada T et al (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980–988CrossRefPubMed Hay ID, Hutchinson ME, Gonzalez-Losada T et al (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980–988CrossRefPubMed
9.
go back to reference DeGroot LJ, Kaplan EL, McCormick M, Straus FH (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414–424CrossRefPubMed DeGroot LJ, Kaplan EL, McCormick M, Straus FH (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414–424CrossRefPubMed
10.
go back to reference Sobin LH, Ch Wittekind (eds) (2002) UICC: TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York Sobin LH, Ch Wittekind (eds) (2002) UICC: TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York
11.
go back to reference Antonelli A, Miccoli P, Ferdeghini M (1995) Role of neck ultrasonography in follow-up of patients operated on for differentiated thyroid cancer. Thyroid 5:25–29CrossRefPubMed Antonelli A, Miccoli P, Ferdeghini M (1995) Role of neck ultrasonography in follow-up of patients operated on for differentiated thyroid cancer. Thyroid 5:25–29CrossRefPubMed
12.
go back to reference Uruno T, Miyauchi A, Shimizu K et al (2005) Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg 29:483–485CrossRefPubMed Uruno T, Miyauchi A, Shimizu K et al (2005) Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg 29:483–485CrossRefPubMed
13.
go back to reference DeGroot LJ, Kaplan EL, Straus FH, Shukla MS (1994) Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 18:123–130CrossRefPubMed DeGroot LJ, Kaplan EL, Straus FH, Shukla MS (1994) Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 18:123–130CrossRefPubMed
14.
go back to reference Ito Y, Uruno R, Nakano K et al (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13:381–388CrossRefPubMed Ito Y, Uruno R, Nakano K et al (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13:381–388CrossRefPubMed
15.
go back to reference Ito Y, Tomoda C, Uruno T et al (2004) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28:1115–1121CrossRefPubMed Ito Y, Tomoda C, Uruno T et al (2004) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28:1115–1121CrossRefPubMed
16.
go back to reference Dralle H, Gimm O (1996) Lymphadenektomie beim schilddrusencarcinom [in German]. Chirurg 67:788–806CrossRefPubMed Dralle H, Gimm O (1996) Lymphadenektomie beim schilddrusencarcinom [in German]. Chirurg 67:788–806CrossRefPubMed
17.
go back to reference Martenson H, Terins J (1985) Recurrent laryngeal nerve palsy in thyroid gland surgery related to operations and nerves at risk. Arch Surg 120:475–482 Martenson H, Terins J (1985) Recurrent laryngeal nerve palsy in thyroid gland surgery related to operations and nerves at risk. Arch Surg 120:475–482
18.
go back to reference Scheumann GF, Seeliger H, Musholt TF et al (1996) Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 162:677–684PubMed Scheumann GF, Seeliger H, Musholt TF et al (1996) Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 162:677–684PubMed
Metadata
Title
Excellent Prognosis of Patients with Solitary T1N0M0 Papillary Thyroid Carcinoma Who Underwent Thyroidectomy and Elective Lymph Node Dissection Without Radioiodine Therapy
Authors
Yasuhiro Ito
Hiroo Masuoka
Mitsuhiro Fukushima
Hiroyuki Inoue
Minoru Kihara
Chisato Tomoda
Takuya Higashiyama
Yuuki Takamura
Kaoru Kobayashi
Akihiro Miya
Akira Miyauchi
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 6/2010
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-009-0356-0

Other articles of this Issue 6/2010

World Journal of Surgery 6/2010 Go to the issue